Practica Capital Overview
- Investor Type
-
Venture Capital
- Status
-
Active
- Professionals
-
6

- Investments
-
103
- Portfolio
-
37
- Exits
-
38

Practica Capital General Information
Company Description
Founded in 2011, Practica Capital is a venture capital investment firm based in Vilnius, Lithuania. The firm is an early-stage Venture Capital dedicated to backing Baltic founders. They have invested exclusively in tech potential in the Baltic States for over 10 years. They back great founders in their ambition in seed and selected pre-seed and A stages, partnering with them as company builders. They are Baltic syndicate partners co-investing with local, regional, and international VCs, accelerators and incubators, angels, corporates, public agencies, and others.
Business Details
Website
www.practica.vcYear Founded
Investor Status
Trade Association
Primary Investor Type
Corporate Office
- Vilnius Tech Park
- Antakalnio 17-2
- Vilnius, LT-10312
- Lithuania
Practica Capital Investments (103)
Company Name | Deal Date | Deal Type | Deal Size | Industry | Company Stage | Lead Partner |
---|---|---|---|---|---|---|
Atrandi Biosciences | 18-Feb-2025 | Later Stage VC | Biotechnology | Generating Revenue | ||
Qminder | 12-Nov-2024 | Business/Productivity Software | Generating Revenue | |||
AMLYZE | 02-Oct-2024 | Business/Productivity Software | Generating Revenue | |||
Biomatter | 05-Aug-2024 | Biotechnology | Generating Revenue | |||
Spike | 04-Jun-2024 | Enterprise Systems (Healthcare) | Generating Revenue | |||
CTO2B | 17-Apr-2024 | Business/Productivity Software | Generating Revenue | |||
Edurio | 17-Apr-2024 | Business/Productivity Software | Generating Revenue | |||
eany.io | 02-Apr-2024 | Other Commercial Services | Generating Revenue | |||
Evergrowth | 29-Mar-2024 | Seed Round | Consulting Services (B2B) | Generating Revenue | ||
Sentante | 21-Dec-2023 | Seed Round | Biotechnology | Generating Revenue |
Practica Capital Exits (38)
Company Name | Exit Date | Exit Type | Exit Size |
---|---|---|---|
Trafi | 14-Apr-2025 | Merger/Acquisition | |
Watalook | 20-Dec-2024 | ||
Manodaktaras.lt | 19-Dec-2024 | ||
medDream | 26-Jun-2024 | ||
ZitiCity | 29-Jan-2024 | ||
PVcase | 17-Jul-2023 | ||
AdDuplex | 05-Jul-2023 | ||
APL Fresh Food | 01-Apr-2023 | ||
Pinfishing | 01-Mar-2023 | Secondary Transaction - Private | |
Robert Kalinkin | 01-Jan-2023 | Secondary Transaction - Private |
Practica Capital Fund Performance
Fund Name | Vintage | Size | Dry Powder | DPI | RVPI | TVPI | IRR |
---|
Practica Capital Investments by Industry, Year, and Region
Practica Capital Co-Investors (61)
Name | With | Exits | Lead Partner | Series | Industry |
---|---|---|---|---|---|
Metaplanet Holdings | 4 |
![]() |
![]() |
||
CoInvest Capital |
![]() |
![]() |
|||
Lemonade Stand (Estonia) |
![]() |
![]() |
|||
Open Circle Capital |
![]() |
![]() |
|||
Tesi |
![]() |
![]() |
Practica Capital FAQs
-
What is Practica Capital?
Founded in 2011, Practica Capital is a venture capital investment firm based in Vilnius, Lithuania.
-
When was Practica Capital founded?
Practica Capital was founded in 2011.
-
Where is Practica Capital headquartered?
Practica Capital is headquartered in Vilnius, Lithuania.
-
What is Practica Capital's total asset value?
Practica Capital has around
in total assets under management. -
How many investments has Practica Capital made?
Practica Capital has made 103 investments.
-
What has Practica Capital invested in?
Practica Capital has made numerous investments in companies like Atrandi Biosciences, Qminder, and AMLYZE within the Biotechnology and Business/Productivity Software industries.
-
What has Practica Capital invested in recently?
Practica Capital's latest investment was on 18-Feb-2025 in Atrandi Biosciences, a company within the Biotechnology industry.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read blog » -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process »